HLA Laboratory (Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas), HLA-Lab
General information
Personnel
- Ramces Falfan-Valencia, Principal Investigator
Phone: 54871700
Email: rfalvanv@iner.gob.mx - Alejandro Ortega-Martinez, Staff
Phone: 5584113636
Email: aortegam1805@alumno.ipn.mx - Enrique Ortiz, Informatics staff
Phone: 54871700
Email: e_ambrocio_iner@hotmail.com - Marco Ponce-Gallegos, Staff
Phone: 311419479
Email: marcoapg@iner.gob.mx - Guadalupe Armando Zazueta-Márquez, Staff
Phone: 6671012633
Email: guadalupe.zazueta.fb@uas.edu.mx
Assertion criteria
Level: Assertion criteria not provided
Summary of submissions to ClinVar
Total submissions: 118
Gene
Gene | Submissions | Last Updated |
---|---|---|
ACE | 1 | Jan 7, 2023 |
ADAM33 | 1 | Dec 21, 2022 |
ADRB1 | 1 | Jul 5, 2022 |
AGER | 4 | Oct 11, 2023 |
ARNT2 | 2 | Jul 5, 2022 |
ATP2B2 | 2 | Oct 19, 2023 |
BMAL2 | 3 | Jul 5, 2022 |
CHRNA5 | 1 | Dec 21, 2022 |
CYP11A1 | 1 | Jul 5, 2022 |
CYP19A1 | 1 | Jul 5, 2022 |
CYP2C8 | 3 | Jul 5, 2022 |
CYP2C9 | 2 | Jul 5, 2022 |
CYP2J2 | 1 | Jul 5, 2022 |
CYP2R1 | 2 | Jul 5, 2022 |
CYP46A1 | 1 | Jul 5, 2022 |
CYP4A22 | 1 | Jul 5, 2022 |
CYP4B1 | 1 | Jul 5, 2022 |
CYP4Z1 | 1 | Jul 5, 2022 |
DOCK2 | 1 | Oct 19, 2023 |
DSP | 3 | Jun 8, 2021 |
F5 | 1 | Jul 8, 2021 |
FAM13A | 6 | Jun 8, 2021 |
GSTP1 | 1 | Jul 5, 2022 |
HHIP | 6 | Jul 8, 2020 |
HSPA1A | 4 | Nov 3, 2019 |
HSPA1B | 2 | Nov 3, 2019 |
HSPA1L | 1 | Nov 3, 2019 |
IFNAR2 | 8 | Oct 19, 2023 |
IFNAR2-IL10RB | 8 | Oct 19, 2023 |
IL1B | 3 | Mar 30, 2020 |
LOC107063610 | 2 | Nov 3, 2019 |
LOC126805899 | 1 | Jul 5, 2022 |
MGST1 | 4 | Jul 5, 2022 |
MGST3 | 6 | Jul 5, 2022 |
MIR4713HG | 1 | Jul 5, 2022 |
MUC5B | 1 | Jun 13, 2022 |
PADI2 | 4 | Jul 2, 2020 |
PADI4 | 4 | Jul 2, 2020 |
PIRC66 | 1 | Jul 5, 2022 |
SCGB1A1 | 1 | Mar 16, 2021 |
SERPINA1 | 2 | Feb 13, 2024 |
SERPINE1 | 1 | Jul 8, 2021 |
TERT | 3 | Jun 8, 2021 |
TLR4 | 3 | Oct 19, 2023 |
TMPRSS2 | 1 | Oct 19, 2023 |
TNF | 4 | Aug 18, 2021 |
TNFRSF1A | 6 | Oct 19, 2023 |
TNFRSF1B | 6 | Oct 19, 2023 |
TOLLIP | 5 | Jun 8, 2021 |
Condition
Name | Submissions | Last Updated |
---|---|---|
Abnormal pulmonary interstitial morphology | 8 | Jul 2, 2020 |
Antisynthetase syndrome | 3 | Mar 30, 2020 |
Associated with severe COVID-19 disease | 11 | Oct 19, 2023 |
COPD, severe early onset | 6 | Oct 19, 2023 |
Chronic obstructive pulmonary disease | 21 | Jun 8, 2021 |
Chronic obstructive pulmonary disease, biomass related | 3 | Jul 8, 2020 |
Combined pulmonary fibrosis-emphysema syndrome | 4 | Jun 8, 2021 |
Interstitial lung disease 2 | 5 | Jun 8, 2021 |
Mortality risk in patients with severe coronavirus disease (COVID-19) | 5 | May 19, 2022 |
Pulmonary disease, chronic obstructive, susceptibility to | 31 | Jul 5, 2022 |
Rheumatoid arthritis | 8 | Jul 2, 2020 |
Risk of requirement of invasive mechanical ventilation in patients with severe COVID-19 | 1 | Jan 7, 2023 |
Susceptibility to coronavirus disease (COVID-19) severity and mortality due to low plasma levels of MUC5B | 1 | Jun 13, 2022 |
Susceptibility to severe coronavirus disease (COVID-19) | 9 | Feb 13, 2024 |
Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process | 2 | Jul 8, 2021 |
Susceptibility to severe coronavirus disease (COVID-19) due to high levels of fibrinogen and C-reactive protein | 1 | Dec 21, 2022 |
Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR2 | 1 | Aug 18, 2021 |
Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR3 | 1 | Aug 18, 2021 |
Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR4 | 1 | Aug 18, 2021 |
Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR5 | 1 | Aug 18, 2021 |
Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR6 | 1 | Aug 18, 2021 |
Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR7 | 1 | Aug 18, 2021 |
not specified | 1 | Dec 21, 2022 |